Overzicht Proefschriften
Tips in using the search/filter fieldsGo to page:
- of 6
- >
Displaying 1-50 of 278 results.
Titel | Promovendus | Promotor 1 | Promotor 2 | Copromotor 1 | Copromotor 2 | Universiteit | Promotiejaar | Trefwoorden |
---|---|---|---|---|---|---|---|---|
Angiotensin II-induced vasodilation: role of bradykinin, NO and endothelium-derived hyperpolarizing factors | Batenburg W.W., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2005 | Cardiovascular disease; Pharmacology; | |||
Cardiac aldosterone: origin and effects | Chai W., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2005 | Cardiovascular disease; Pharmacology; | |||
Unraveling the complexities of the renin-angiotensin system: from ACE to renin inhibition | Esch J.H.M. van, dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2008 | Cardiovascular disease; Pharmacology; Renin-angiotensin system; | |||
(Pro)renin revisited: new insights from studies in mast cells | Krop M., dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2009 | Cardiovascular disease; Pharmacology; Prorenin; | |||
Aortic pathology and the role of the renin-angiotensin system | Molzer E., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Cardiovascular disease; Renin-angiotensin system; | |||
The more complex renin-angiotensin system: new insights into an old system | Gembardt F., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Pharmacology; Renin-angiotensin system; | |||
Cardiovascular, renal and thyroid toxicity during angiogenesis inhibition: a translational approach | Kappers M.H.W., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2011 | Cancer; Pharmacology; Antihypertensive drugs; | |||
The role of aldosterone and aldosterone blockade in hypertension | Jansen P.M., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2013 | Cardiovascular disease; Antihypertensive drugs; Pharmacology; | |||
Preeclampsia, the renin-angiotensin-aldosterone system and beyond | Verdonk K., PhD | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2015 | Pre-eclampsia; Antihypertensive drugs; Pharmacology; Primary care; Renin-angiotensin system; | |||
Neuropharmacology of novel dopamine modulators | Beek E.T te, PhD | Gerven J.M.A. van, prof. dr. | Cohen A.F., prof. dr. | Universiteit Leiden (UL) | 2014 | Dopamine Antagonist Drug development Pharmacokinetics Pharmacodynamics Schizophrenia Drug addiction Tachykinins | ||
Drug-induced psychomimetic symptoms as a model for psychosis | Kleinloog-Fernández González H.D., PhD | Gerven J.M.A. van, prof. dr. | Cohen A.F., prof. dr. | Universiteit Leiden (UL) | 2014 | Clinical Pharmacology Psychotic Disorders Clinical Trial Drug evaluation Biological Models | ||
Novel approaches in clinical development of cannabinoid drugs | Klumpers L.E., PhD | Gerven J.M.A. van, prof. dr. | Cohen A.F., prof. dr. | Universiteit Leiden (UL) | 2014 | Cannabinoids; THC; CB1 antagonists; Pharmacokinetics; Clinical pharmacology; Pharmacodynamics; Feeling high; PK-PD modelling; Resting state FMRI; Rimonabant; | ||
Cognition in Huntington's disease : the influence of motor behaviour and time | Hart E.P. 't, PhD | Roos R.A.C., prof. dr. | Universiteit Leiden (UL) | 2013 | Huntington's disease; Cognition; Movement disorder; Executive functioning; Memory; P300; Motor behaviour | |||
Clinical pharmacology of nevirapine in HIV-infected patients in Tanzania | Muro E.P., PhD | Burger D.M., prof. dr. | Dolmans W.M.V., prof. dr. | Radboud Universiteit (RU) | 2014 | Clinical pharmacology; HIV; Pharmacokinetics; therapy drug monitoring | ||
Assessment of ischaemia and reperfusion injury | Wouters C.W., PhD | Rongen G.A., prof. dr. | Oyen W.J.G., prof. dr. | Radboud Universiteit (RU) | 2013 | Ischemia/reperfusion injury; adenosine; atorvastatin; forearm; | ||
The role of efflux and influx transporters in the disposition of digitalis-like compounds | Gozalpour E., PhD | Russel F.G.M., prof. dr. | Radboud Universiteit (RU) | 2015 | ||||
The many faces of Na+, K+-ATPase: understanding the role of human isoforms in health and disease | Weigand K.M., PhD | Russel F.G.M., prof. dr. | Radboud Universiteit (RU) | 2015 | ||||
Vascular adaptation to pregnancy and relaxin | Drongelen J. van, PhD | Smits P., prof. dr. | Lotgering F.K., prof. dr. | Radboud Universiteit (RU) | 2014 | |||
Medication safety through information technology; a focus on medication prescribing and administering. | Helmons P.J., PhD | Kosterink J.G.W., prof. dr. | Daniels C.E., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2014 | medication safety information technology prescribing and administering drugs | ||
Optimizing cancer therapy. A focus on molecular imaging | Gaykema S.B.M., PhD | Vries E.G.E. de, prof. dr. | Lub-de Hooge M.N., dr. | Rijksuniversiteit Groningen (RUG) | 2014 | |||
Novel biomarker panels in diabetic kidney disease: predicting disease progression and response to therapy, and monitoring drug effect | Pena M.J., PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2015 | Biomarkers; Diabetes mellitus; Kidney; | ||
Integrating biomarkers to predict renal and cardiovascular drug efficacy: PRE score applications from drug registration to personalized medicine | Schievink B.H., PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2016 | PRE score; Risk markers; Chronic kidney disease; Personalized medicine; | ||
The association between albuminuria and long-term renal risk; how to improve the precision of drug effect estimates | Kröpelin T.F., PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2016 | Kidney; Diabetic kidney disease; Drug efficacy; | ||
Experimental focal cerebral ischemia: optimalisation of models and therapeutic interventions | Shanbhag N.C., PhD | Henning R.H., prof. dr. | Schilling L., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2016 | Cerebral ischemia; | ||
Pharmacological modulation of ischemia and reperfusion injury | Meijer P., PhD | Rongen G.A., prof. dr. | Smits P., prof. dr. | Radboud Universiteit (RU) | 2012 | Ischemia/Reperfusion injury; rosuvastatin; adenosine; forearm; | ||
Human in vivo studies on the non-glycaemic effects of thiazolidinedione derivatives | Rennings A.J.M., PhD | Smits P., prof. dr. | Tack C.J.J., prof. dr. | Radboud Universiteit (RU) | 2014 | |||
Exposure to antiretroviral agents in hiv-infected pregnant women: not too much-not too little | Colbers E.P.H., PhD | Burger D.M., prof. dr. | Radboud Universiteit (RU) | 2015 | HIV; antiretroviral agents; clinical pharmacology; drug drug interactions | |||
Making things easier: how to improve antiviral drug treatment for children | Bastiaans D.E.T., dr. | Burger D.M., prof. dr. | Radboud Universiteit (RU) | 2016 | Clinical pharmacology; Antiviral drug treatment; | |||
Size does matter : drug glucuronidation in children | Krekels E.H.J., PhD | Knibbe C.A.J., prof. dr. | Tibboel D., prof. dr. | Universiteit Leiden (UL) | 2012 | Paediatrics; Morphine; Population PK; System-specific covariate modelling; Model validation; Glucuronidation; Ontogeny; Pharmacokinetics; UGT2B7; Zidovudine; | ||
Pain still hurts : pain assessment and pain management in intensive care patients | Ahlers S.J.G.M., PhD | Tibboel D., prof. dr. | Knibbe C.A.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2012 | Morphine; Remifentanil; Pain; Immune reconstitution; Intensive care; Critically ill; Analgesia; Anesthesiology; Pain assessment; Pain management; | ||
Exploring optimal pharmacotherapy after bariatic surgery: where two worlds meet | Yska J.P., PhD | Roon E.N. van, prof. dr. | Wilffert B, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2017 | Optimal pharmacotherapy; Bariatric surgery; | ||
Modulation of endogenous H2S productin: its role in hibernation and pharmacological cell protection | Talaei F., PhD | Henning R.H., prof. dr. | Schmidt M., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2012 | Hibernation; Endogenous H2S production; Pharmacological cell protection; Hypothermia; Cysteinyldopa; | ||
Off-target effects of RAAS-inhibition: importance on renal outcomes in patients with diabetes | Miao Y., PhD | Groen A.K., prof. dr. | Zeeuw D. de, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2012 | RAAS-inhibition; Diabetes mellitus; | ||
Renin-Synthesizing Cells and Beyond | Goes Martini A., PhD | Danser A.H.J., prof. dr. | Neves F.A.R., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2017 | Renin-angiotensin system; Renal function; | ||
Endothelial dysfunction in cardiovascular disease | Heuvel M. van den, PhD | Duncker D.J.G.M., Prof.dr. | Danser A.H.J., prof. dr. | Erasmus Universiteit Rotterdam (EUR) | 2018 | Cardiovascular disease; Vascular reactivity; Cholesterol; | ||
Evaluation of renal end points in nephrology trials. | Weldegiorgis M | Lambers Heerspink H.J., prof. dr. | Zeeuw D. de, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2017 | Pharmacology; Nephrology trials; renal endpoints | ||
Advanced vascular imaging : technical and clinical applications in type 2 diabetes | Boer S.A. de, PhD | Kamphuisen T.P.W., prof. dr. | Slart R.H.J.A., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2017 | Pharmacology; advanced vascular imaging; Diabetes mellitus; | ||
Albuminuria: more than a renal risk marker? | Belt S.M. van den, PhD | Zeeuw D. de, prof. dr. | Lambers Heerspink H.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2018 | Albuminuria; Risk markers; | ||
Towards understanding interchangeability of generic drugs | Yu Y, dr | Neef C., prof. dr. | Burger D.M., prof. dr. | Universiteit Maastricht (UM) | 2017 | |||
Pharmacy Preparations: European quality standards and regulation | Scheepers H., dr | Neef C., prof. dr. | Universiteit Maastricht (UM) | 2017 | Pharmacy policy; | |||
Medication management in homecare patients | Sino C.G.M., PhD | Schuurmans M.J., prof. dr. | Egberts A.C.G., prof. dr. | Universiteit Utrecht (UU) | 2013 | |||
Pharmacological approaches to optimize TB treatment | Zuur M.A. | Alffenaar J.W.C., prof. dr. | Werf T.S. van der, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2018 | Optimize; Tuberculosis; Treatment; | ||
The pursuit of user-friendly medicines : older people in the hot seat | Notenboom K., PhD | Bouvy M.L., prof. dr. | Leufkens H.G.M., prof. dr. | Universiteit Utrecht (UU) | 2017 | Usability; User-friendly; Older patients; Elderly; Medicines; Medication use; Medication errors; Tablet breaking; Swallowing; Medication packaging; | ||
Clinical pharmacology of novel anticancer drug formulations | Stuurman F.E, PhD | Schellens J.H.M., prof. dr. | Beijnen J.H., prof. dr. | Universiteit Utrecht (UU) | 2013 | Clinical pharmacology; Cancer; | ||
Use of real-world evidence in pharmaeconomic analysis | Huang Y. | Haaijer-Ruskamp F.M., prof. dr. | Postma M.J., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2019 | Pharmacogenomics; | ||
Therapeutic drug monitoring in tuberculosis treatment | Elsen S.H.J. van den | Alffenaar J.W.C., prof. dr. | Werf T.S. van der, prof. dr. | Rijksuniversiteit Groningen (RUG) | 2020 | drug monitoring, tuberculosis treatment | ||
Implementing dried blood spot sampling in transplant patient care | Touw D.J., prof. dr. | Touw D.J., prof. dr. | Bakker S.J.L., prof. dr. | Rijksuniversiteit Groningen (RUG) | 2020 | dried blood spot sampling, transplant patient care | ||
Characterization and re-evaluation of experimental pain models in healthy subjects | Siebenga P.S | Cohen A.F., prof. dr. | Universiteit Leiden (UL) | 2020 | Analgesics Human evoked pain models Neuropathic pain Nociceptive pain Pharmacodynamics Phase-1 clinical triala | |||
Future drugs in atherosclerotic cardiovascular disease | Poelgeest E.P van | Burggraaf J., prof. dr. | Cohen A.F., prof. dr. | Universiteit Leiden (UL) | 2018 | Atherosclerosis Systemic inflammation Hypercholesterolemia PCSK9 inhibitor TLR4 sinaling Acute kidney injury Endothelial dysfunction Human endotoxemia model Ex vivo LPS challenge test Invivo LPS challenge test | ||
The use of a battery of evoked pain models in early phase drug development | Okkerse P. | Cohen A.F., prof. dr. | Groeneveld G.J., prof. dr. | Universiteit Leiden (UL) | 2018 | Pain Human pain models Analgesics Clinical pharmacology Pharmacodynamics Drug Development |
Go to page:
- of 6
- >